Status:
COMPLETED
Immediate Pain Relieving Effects of Sinbaro-3 for Low Back Pain
Lead Sponsor:
Jaseng Hospital of Korean Medicine
Conditions:
Low Back Pain With Radiculopathy
Low Back Pain Without Radiculopathy
Eligibility:
All Genders
18-69 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to investigate the immediate pain relieving effects of sinbaro-3 pharmaco-acupuncture in patients with low back pain admitted for inpatient care
Detailed Description
60 patients with LBP with moderate to severe pain(NRS\>6) were randomly allocated to 2 groups. The experimental group was treated with sinbaro-3 pharmacoacupuncture and the control group was treated w...
Eligibility Criteria
Inclusion
- Patients admitted to a Korean Medicine hospital for low back pain with or without radiculopathy
- Age between 18 and 69
- NRS score of \>6 on the day of the intervention
- Voluntary participation with written consent given to study consent form
Exclusion
- Diagnosis of serious disease(s) which are possible causes of back pain such as malignancy, vertebral fracture, spinal infection, inflammatory spondylitis, cauda equina compression, etc.
- Prior diagnosis of other chronic disease(s) which could affect effectiveness or interpretation of treatment results such as cardiovascular disease, diabetic neuropathy, fibromyalgia, rheumatoid arthritis, Alzheimer's disease, epilepsy, etc.
- Progressive neurologic deficit(s) or concurrent severe neurological symptoms
- Unsuitable for or at risk of complications from acupuncture treatment such as patients with clotting disorders, severe diabetes with risk of infection, serious cardiovascular disease, or undergoing anticoagulant treatment, etc.
- Under prescription of corticosteroids, immuno-suppressant drugs, psychiatric medicine, or other medication considered unsuitable for subjects by the researcher
- Experience of gastroenteric complications after taking NSAIDs or currently undergoing treatment for digestive disorders
- During pregnancy or suspected pregnancy
- Subjects considered unsuitable for clinical trial by the researcher
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02196129
Start Date
July 1 2014
End Date
November 1 2014
Last Update
November 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, South Korea, 135-896